Acro Biomedical (ACBM) Income from Continuing Operations (2016 - 2025)
Acro Biomedical (ACBM) recorded quarterly Income from Continuing Operations of 42526.0 in Q4 2025, up 136.1% quarter-over-quarter from 117809.0 in Q3 2025, and up 498.44% on a YoY basis from 7106.09 in Q4 2024.
Acro Biomedical (ACBM) Income from Continuing Operations (2016 - 2025) Analysis & Trends
Acro Biomedical's Income from Continuing Operations history runs 10 years deep, the most recent figure standing at 42526.0 for Q4 2025.
- In Q4 2025, Income from Continuing Operations rose 498.44% year-over-year to 42526.0; the TTM figure through Dec 2025 stood at 101146.0 (down 139.13% YoY), while the FY2025 annual figure was 101146.0, down 139.13% from the prior year.
- Income from Continuing Operations was 42526.0 for Q4 2025 at Acro Biomedical, up from 117809.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 42526.0 in Q4 2025 to a low of 4011322.0 in Q3 2022.
- Historically, Income from Continuing Operations has averaged 1625846.5 across 5 years, with a median of 456248.0 in 2021.
- The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations tumbled 6503.69% in 2022, then soared 498.44% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 3849456.0 in 2021, then slipped by 2.21% to 3934681.0 in 2022, then surged by 99.54% to 18240.0 in 2023, then jumped by 41.49% to 10673.0 in 2024, then jumped by 498.44% to 42526.0 in 2025.
- The last three Income from Continuing Operations figures came in at 42526.0 (Q4 2025), 117809.0 (Q3 2025), and 15562.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | 3.87 Mn |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | 2.89 Mn |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | 2.22 Mn |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | 1.49 Mn |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | 2.52 Mn |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | 2.75 Mn |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | -612,993.00 |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | 2.17 Mn |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | 1.14 Mn |
| 10 | Acro Biomedical | - | - | - | 42,526.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 42,526.00 |
| Sep 30, 2025 | -117,809.00 |
| Jun 30, 2025 | -15,562.00 |
| Mar 31, 2025 | -10,301.00 |
| Dec 31, 2024 | -10,673.00 |
| Sep 30, 2024 | -10,229.00 |
| Jun 30, 2024 | -10,143.00 |
| Mar 31, 2024 | -11,252.00 |
| Dec 31, 2023 | -18,240.00 |
| Sep 30, 2023 | -1.59 Mn |
| Jun 30, 2023 | -3.20 Mn |
| Mar 31, 2023 | -4.00 Mn |
| Dec 31, 2022 | -3.93 Mn |
| Sep 30, 2022 | -4.01 Mn |
| Jun 30, 2022 | -4.00 Mn |
| Mar 31, 2022 | -3.93 Mn |
| Dec 31, 2021 | -3.85 Mn |
| Sep 30, 2021 | -2.99 Mn |
| Jun 30, 2021 | -794,687.00 |
| Mar 31, 2021 | -59,494.00 |